PA GOODDOCTOR (01833) Wins WISE2025 "King of Business" Award for Breakthrough in AI Application Scenarios

Stock News
2025/12/01

On November 27, the WISE2025 "King of Business" conference was held in Beijing. PA GOODDOCTOR (01833) was honored with the "Breakthrough in AI Application Scenarios" award for its deep integration of artificial intelligence into healthcare services.

The WISE2025 "King of Business" event is a premier annual gathering focusing on trending sectors such as AI, globalization, and branding. The "Breakthrough in AI Application Scenarios" award recognizes companies that have successfully commercialized AI technologies across diverse fields, including large-scale models, AIGC, robotics, and autonomous driving.

PA GOODDOCTOR's win underscores its technological prowess and practical application capabilities, earning industry-wide recognition. Aligned with China's strategic goal of technological self-reliance, the company has actively advanced its "AI+" initiative, integrating AI with healthcare to enhance service quality and efficiency.

This year, PA GOODDOCTOR launched its "7+N+1" medical AI product ecosystem, creating a closed-loop system of data, models, and application scenarios to improve end-to-end healthcare services. Its flagship "AI Family Doctor" features a three-tier product matrix—AI doctors, AI assistants, and AI-MDT—operating under a strict "AI suggestion + physician oversight" safety protocol.

Currently, AI-assisted consultations achieve an accuracy rate of approximately 98%, while complex disease MDT treatment plans reach nearly 90% accuracy. AI-supported doctors can handle up to 4 million daily consultations.

Moving forward, PA GOODDOCTOR will continue to innovate and refine its AI-driven healthcare solutions, prioritizing user needs to deliver comprehensive, high-quality, and compassionate medical services across all scenarios.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10